GlassScriptPhysician profile
Brian K Metz
NPI 1770588303
$6,038.68
in general payments reported to CMS, 2019-2025
36 companies · $1,183 in 2025
The $1,183 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,045 · 2020: $86.06 · 2021: $183 · 2022: $907 · 2023: $1,084 · 2024: $1,551 · 2025: $1,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,818.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,024.09 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $809.20 | 2019-2025 | |
| Pfizer INC. | $752.24 | 2019-2025 | |
| Edwards Lifesciences Corporation | $450.33 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Inspiris Resilia Aortic Valve, Sapien 3 Ultra Resilia |
| Amgen INC. | $382.47 | 2019-2025 | Repatha, Repatha |
| Heartflow, INC. | $365.41 | 2024-2025 | |
| Boston Scientific Corporation | $279.41 | 2019-2024 | Watchman Access System |
| Philips North America LLC | $261.70 | 2020-2025 | (Ck4) Mcot, Extended Holter, (Ck7) Extended Holter |
| Janssen Pharmaceuticals, INC | $235.91 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $208.13 | 2019-2023 | |
| Alnylam Pharmaceuticals INC. | $153.54 | 2023-2025 | Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $151.79 | 2019-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.46 | 2019-2022 | |
| Astellas Pharma US INC | $86.61 | 2019 | |
| Inspire Medical Systems, INC. | $79.95 | 2024-2025 | Inspire |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $78.70 | 2022-2024 | Verquvo |
| Ge Healthcare | $64.50 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $64.49 | 2022 | |
| Bardy Diagnostics, INC. | $54.01 | 2022 | |
| Impulse Dynamics (USA) INC. | $47.55 | 2022 | |
| Scpharmaceuticals INC. | $42.31 | 2024 | |
| Bridgebio Pharma, INC. | $29.96 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals LP | $28.73 | 2019-2023 | Farxiga |
| Medtronic, INC. | $27.55 | 2023 | Linq II |
| Abiomed | $24.54 | 2024 | Impella |
| Esperion Therapeutics, INC. | $23.74 | 2021 | |
| Kestra Medical Technology Services, INC. | $23.63 | 2023 | Assure Wcd |
| Medtronic Vascular, INC. | $21.86 | 2019 | |
| Gilead Sciences, INC. | $21.29 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $20.82 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $18.99 | 2022 | |
| Amarin Pharma, INC. | $18.51 | 2019 | |
| Atricure, INC. | $18.35 | 2025 | Epi-Ease Epicardial Access System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Abbott Laboratories | $17.52 | 2019 | |
| Daiichi Sankyo INC. | $17.49 | 2023 | Injectafer |
| Akcea Therapeutics, INC. | $15.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Metz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.